Navigation Links
Health Diagnostic Laboratory Inc. Announces New Preventative Model to Chronic Disease Management
Date:1/18/2010

RICHMOND, Va., Jan. 18 /PRNewswire/ -- Health Diagnostic Laboratory Inc. (HDL), www.hdlabinc.com, announced today the launch of its new preventative model to chronic disease management based off a monumental shift in the way physicians test for life threatening conditions.  "The medical community is no longer confined to limited lab results, and is now in a position to more accurately detect the unexpected," said Tonya Mallory, President and CEO, HDL Inc.  "Few moments in medical history have held such promise and opportunity for the prevention of cardiovascular and related chronic diseases while enhancing the continuum of care."

Health Diagnostic Laboratory Inc., headquartered in a new state-of-the-art facility in the Virginia BioTechnology Research Park, offers a comprehensive panel of tests to help physicians personalize treatment based on an expanded, total patient profile.  As a result, HDL Inc. provides more advanced evidence-based treatments, earlier detection of residual risk factors pre-disposing patients to disease and fewer patients progressing to overt disease.

For example, half the people with coronary artery disease have had blood cholesterol levels similar to those of people who have not developed the disease.  As a result, there has been a marked change in the overall scientific understanding of the role of "good" and "bad" cholesterol in metabolic disorders and coronary heart disease (CHD) events. "After 50-plus years of research it is now proven that physicians must measure more in order to understand a patient's overall risks," Mallory said.  

HDL Inc.'s new preventative model approach provides physicians with more advanced tools and scientific evidence to predict angiographic disease or coronary heart disease events.  Positioned as a partner to both the physician and the patient, HDL Inc. moves beyond total cholesterol and outdated measurement techniques, and instead provides physicians with comprehensive and accurate information that surpasses the reach of conventional HDL and LDL analysis.  Physicians therefore can do more than diagnose disease; they can focus on all of the cholesterol components and residual risk factors or biomarkers and their impact on overall heath.  

The founders of HDL Inc., an accredited clinical laboratory, have a rich history of serving at the forefront of renowned medical, educational and industrial institutions.  HDL Inc. uses a comprehensive systems biology approach to eliminate surprises and reverse the alarming increase in chronic disease by providing physicians with:

  • access to targeted disease management services for their patients
  • improved compliance with treatment plans
  • clinical educators to increase patient satisfaction

"HDL Inc. works diligently as a partner with both physician and patient to understand disease and provide support to identify and reverse health risks," said Mallory.  HDL Inc.'s advanced testing options allow physicians to understand their patients' disease on a personal level and to support the individual achievement of health in a way that was never before possible.  

www.hdlabinc.com

SOURCE Health Diagnostic Laboratory Inc.

RELATED LINKS
http://www.hdlabinc.com

'/>"/>

SOURCE Health Diagnostic Laboratory Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health
3. BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health
4. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
5. Tone Deafness Explained, from the Harvard Health Letter
6. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
7. Opko Health Doses First Patient in Phase 3 COBALT Trial of Bevasiranib for the Treatment of AMD
8. ViroPharma to Present at Three Upcoming Healthcare Conferences
9. AIDS Healthcare Foundation Names Homayoon Khanlou, M.D. as its Chief of Medicine, U.S.
10. The Female Health Company Receives USAID DELIVER PROJECT Order for 5 Million Units
11. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... June 24, 2016  Global Blood Therapeutics, Inc. (GBT) ... developing novel therapeutics for the treatment of grievous ... the closing of its previously announced underwritten public ... the public offering price of $18.75 per share. ... offered by GBT. GBT estimates net proceeds from ...
(Date:6/24/2016)... , June 24, 2016 The Academy of ... recommendations that would allow biopharmaceutical companies to ... entities that make formulary and coverage decisions, a move ... of new medicines. The recommendations address restrictions ... appear on the drug label, a prohibition that hinders ...
(Date:6/24/2016)... 2016 According to a new ... Pen Needles, Safety Pen Needles), Needle Length (4mm, 5mm, ... Mode of Purchase (Retail, Non-Retail) - Trends & Global ... the market for the forecast period of 2016 to ... Billion by 2021 from USD 1.65 Billion in 2016, ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... ... a legally blind and certified personal trainer is helping to develop a weight loss fitness ... to fix the two major problems leading the fitness industry today:, , ... They don’t eliminate all the reasons people quit their exercise program ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX ... Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms over ... Cut Pro X . Simply select a ProHand generator and drag it above media ...
(Date:6/25/2016)... Montreal, Canada (PRWEB) , ... June 25, 2016 , ... ... the pursuit of success. In terms of the latter, setting the bar too high ... low, risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Sessions in Dallas that it will receive two significant new grants to support ... as PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. ... magazine’s Code Talker Award, an essay contest in which patients and their families pay ... be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference ...
Breaking Medicine News(10 mins):